Tricida Inc

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tricida, Inc. is a late-stage pharmaceutical company focused on the development and commercialization of its lead product candidate, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Metabolic acidosis has been associated with increased muscle wasting, loss of bone density and death.

NEW YORK, Jan. 25, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tricida, Inc. (NASDAQ: TCDA) between September 4, 2019 and October 28, 2020, inclusive (the "Class...

ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Tricida, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - TCDA

LOS ANGELES, Jan. 25, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) for violations of §§10(b) and 20(a) of the Securities Exchange...

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tricida, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Pinterest

SolarWinds Corp

NEW YORK, NY / ACCESSWIRE / January 17, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PINS, SWI and TCDA

New York, New York--(Newsfile Corp. - January 15, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Tricida securities between September 4, 2019 and October 28, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's...

TCDA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Tricida, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tricida, Inc. (NASDAQ:TCDA) between September 4, 2019 and October 28, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Tricida investors under the federal securities laws. To join the Tricida class action, go to http://www.rosenlegal.com/cases-register-1941.html or call Phillip Kim, Esq. toll-free

Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tricida, Inc. – TCDA

BENSALEM, Pa.--(BUSINESS WIRE)---- $TCDA #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tricida, Inc. (TCDA) Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tricida, Inc. (TCDA) Investors

LOS ANGELES--(BUSINESS WIRE)---- $TCDA #CLASSACTION--Glancy Prongay & Murray, Leading Securities Fraud Law Firm, Announces Filing of a Securities Class Action on Behalf of Tricida, Inc. (TCDA) Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Tricida, Inc. (TCDA) Investors

LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) for violations of §§10(b) and 20(a) of the Securities Exchange...

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tricida, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

QuantumScape

NEW YORK, NY / ACCESSWIRE / January 10, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PINS, QS and TCDA

BENSALEM, Pa.--(BUSINESS WIRE)---- $TCDA #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Tricida, Inc. (TCDA) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Tricida, Inc. (TCDA) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $TCDA #TCDA--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tricida, Inc.

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tricida, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $TCDA #investors--The Law Offices of Frank R. Cruz Announces Investigation of Tricida, Inc. (TCDA) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Tricida, Inc. (TCDA) on Behalf of Investors

NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Tricida, Inc. (NASDAQ: TCDA) securities between September 4, 2019 and October 28, 2020 (the “Class Period”). Investors have until March 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Cli

TRICIDA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Tricida, Inc. and Encourages Investors to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $TCDA #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tricida, Inc. (TCDA) on Behalf of Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tricida, Inc. (TCDA) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $TCDA #TCDA--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tricida, Inc.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tricida, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

NEW YORK, Jan. 6, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA) and certain of its officers. The class action, filed in United States District Court for the Northern District of...

Pomerantz Law Firm Announces the Filing of a Class Action against Tricida, Inc. and Certain Officers - TCDA

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 11:50 am PT / 2:50 pm ET. Gerrit Klaerner, Ph.D., Tricida's Founder, President and CEO, will provide a company overview, business update and progress on the company's key initiatives.

Tricida to Present at the 39th Annual J.P. Morgan Healthcare Conference

Amarin Corporation Plc

Intercept Pharma

Invesco Mortgage Capital

NGL Energy Partners

Nextcure

PBF Energy

SNDL Inc.

Tellurian

Washington Prime Group

These companies are eager to say good riddance to the year that was.

The 10 Worst Performing Stocks of 2020

SOUTH SAN FRANCISCO, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today key updates on veverimer's development program, regulatory status and patent protection.

Tricida Announces Updates on Veverimer Development Program, Regulatory Status and New Patent Extending Protection through 2038

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that it will provide an end-of-year business update on veverimer's development program, regulatory status and patent protection.

Tricida to Provide an End-of-Year Business Update

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - December 5, 2020) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential claims against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA).On July 15, 2020, Tricida issued a press release disclosing that on July 14, 2020, the Company received a notification from the U.S. Food and Drug Administration ("

Tricida Shareholder Notice

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - November 30, 2020) -  Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential claims against Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA).On July 15, 2020, Tricida issued a press release disclosing that on July 14, 2020, the Company received a notification from the U.S. Food and Drug Administra

Tricida Investor Alert

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today financial results for the three and nine months ended September 30, 2020 and provided an update on key initiatives.

Tricida Announces Third Quarter 2020 Financial Results

NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tricida, Inc. - TCDA

Shares of Tricida Inc (NASDAQ: TCDA) were hitting new lows Thursday following a regulatory update on veverimer, the only investigational asset in its pipeline. What Happened: Following an end-of-review conference held as a Type A meeting, the South San Francisco, California-based company said the FDA sought data on the effect of its investigational drug veverimer on renal disease progression for according accelerated approval.

News for Tricida Inc Stock (TCDA)